IMNM (Immunome, Inc.) Stock Analysis - Analyst Ratings

Immunome, Inc. (IMNM) is a publicly traded Healthcare sector company. As of May 20, 2026, IMNM trades at $21.45 with a market cap of $2.25B and a P/E ratio of -8.89. IMNM moved +9.59% today. Year to date, IMNM is +9.23%; over the trailing twelve months it is +151.52%. Its 52-week range spans $5.15 to $27.65. Analyst consensus is strong buy with an average price target of $35.17. Rallies surfaces IMNM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate IMNM?

14 analysts cover IMNM: 0 strong buy, 14 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $35.17.

IMNM Key Metrics

Key financial metrics for IMNM
MetricValue
Price$21.45
Market Cap$2.25B
P/E Ratio-8.89
EPS$-2.38
Dividend Yield0.00%
52-Week High$27.65
52-Week Low$5.15
Volume1.14M
Avg Volume0
Revenue (TTM)$4.01M
Net Income$-224.59M
Gross Margin0.00%

IMNM Analyst Consensus

14 analysts cover IMNM: 0 strong buy, 14 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $35.17.

Recent IMNM Insider Trades

  • BIENAIME JEAN JACQUES bought 5.00K (~$103.50K) on May 15, 2026.
  • Higgins Jack sold 9.44K (~$204.24K) on Apr 2, 2026.
  • Rosett Max sold 63.66K (~$1.39M) on Apr 2, 2026.

Common questions about IMNM

What do analysts rate IMNM?
14 analysts cover IMNM: 0 strong buy, 14 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $35.17.
Does Rallies show IMNM price targets?
Yes. Rallies tracks IMNM analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is IMNM research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IMNM. It does not provide personalized investment advice.
IMNM

IMNM